BIGNUCOLO, ALESSIA

BIGNUCOLO, ALESSIA  

Università di Padova  

Mostra records
Risultati 1 - 17 di 17 (tempo di esecuzione: 0.029 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Assessment of pharmacogenomic SLCO1B1 assay for prediction of neuromuscular pain in type 2 diabetes mellitus and cardiovascular patients: preliminary results 2020 Marotta G.De Lucia V.Bignucolo A.De Lucia D. + EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES - -
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-related gastrointestinal toxicity in metastatic colorectal cancer patients 2018 Cecchin E.Roncato R.Bignucolo A. + FRONTIERS IN PHARMACOLOGY - -
DEVELOPMENT OF AN INTEGRATED HEALTH IT PLATFORM FOR A PRECISE AND COST-EFFECTIVE THERAPY IN ONCOLOGY 2018 Roncato, RBignucolo, AToffoli, GCecchin, E + BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY - -
Development of an Integrated Health IT Platform for a Precision Medicine Setting 2018 Roncato, RBignucolo, AToffoli, GCecchin, E + PUBLIC HEALTH GENOMICS - -
Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity 2022 Tinazzi, MattiaBignucolo, AlessiaMontopoli, Monica + CANCERS - -
FARMAPRICE: A Pharmacogenetic Clinical decision support system for precise and Cost-Effective Therapy 2019 Roncato R.Bignucolo A.Cecchin E. + GENES - -
Genetic biomarkers for hepatocellular cancer risk in a caucasian population. 2017 Cecchin EBignucolo ARoncato R + WORLD JOURNAL OF GASTROENTEROLOGY - -
Genetic markers of the host to predict the efficacy of colorectal cancer targeted therapy 2019 Bignucolo, AlessiaToffoli, Giuseppe + CURRENT MEDICINAL CHEMISTRY - -
Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI 2019 Roncato R.Bignucolo A. + FRONTIERS IN ONCOLOGY - -
Il15ra and smad3 genetic variants predict overall survival in metastatic colorectal cancer patients treated with folfiri therapy: A new paradigm 2021 Roncato R.Bignucolo A.Gagno S.Cecchin E.Toffoli G. + CANCERS - -
Integrative oncology: evidence-based medicine - The multidisciplinary experience of the Integrative Medicine Research Group (IMRG) 2022 Tinazzi, MBignucolo, AMontopoli, M + EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES - -
Pharmacogenomics of targeted agents for personalization of colorectal cancer treatment 2017 Bignucolo A.Cecchin E.Roncato R. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Resveratrol in cancer patients: From bench to bedside 2020 Bignucolo A. + INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Sex disparities in efficacy in covid-19 vaccines: A systematic review and meta-analysis 2021 Bignucolo A. + VACCINES - -
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy 2021 Roncato, RossanaBignucolo, AlessiaBelluco, ClaudioPucciarelli, Salvatore + FRONTIERS IN PHARMACOLOGY - -
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 2018 ECCA, FABIOBignucolo A.Roncato R.Cecchin E. + CLINICAL PHARMACOLOGY & THERAPEUTICS - -
The Multiple Effects of Vitamin D against Chronic Diseases: From Reduction of Lipid Peroxidation to Updated Evidence from Clinical Studies 2022 Bignucolo, AlessiaSharifi, SamanBressan, SilviaRichter, Sara NCamozzi, ValentinaScaroni, CarlaMontopoli, Monica + ANTIOXIDANTS - -